Description: Lumateperone PTSA salt (ITI-722, ITI-007; Caplyta), the toluenesulfonic acid salt of Lumateperone, is a dual 5HT2A receptor antagonist and dopamine receptor phosphoprotein modulator (DPPM), approved as an atypical antipsychotic in 2019 for the treatment of schizophrenia.

References: Kumar B, Kuhad A, Kuhad A. Lumateperone: a new treatment approach for neuropsychiatric disorders. Drugs Today (Barc). 2018 Dec;54(12):713-719. doi: 10.1358/dot.2018.54.12.2899443. PubMed PMID: 30596390.

Related CAS #: 313368-91-1 (free base) 1187020-80-9 (tosylate)

纯度：≥98%

CAS：1187020-80-9